MetaCap

Who Owns Ocular Therapeutix Stock?

NASDAQ: OCULHealth CareBiotechnology: Pharmaceutical PreparationsUSD

5.57-0.29 (-4.95%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
97.12%
Institutional holders
348
  • Institutions 97.1%
  • Insiders 1.4%
  • Public and other 1.4%

Who owns Ocular Therapeutix stock?

Institutional investors own about 97.1% of Ocular Therapeutix's shares, spread across 348 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 1.44% of OCUL.

The largest institutional holders are FMR, LLC (15.07%), Blackrock Inc. (9.08%) and Deep Track Capital, Lp (8.95%). Together, the top 10 institutions control 61.6% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their OCUL positions and 0 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of OCUL

Ocular Therapeutix top institutional holders
InstitutionShares% HeldChange
FMR, LLC33.16M15.07%+1.0%
Blackrock Inc.19.97M9.08%+3.1%
Deep Track Capital, Lp19.69M8.95%0.0%
Avoro Capital Advisors LLC12.54M5.70%+1.8%
Summer Road LLC12.46M5.66%+2.1%
Venrock Adviser, LLC10.35M4.70%0.0%
Vanguard Capital Management LLC8.94M4.06%+1.2%
Price (T.Rowe) Associates Inc7.62M3.46%+29.3%
State Street Corporation5.58M2.53%+6.5%
Logos Global Management LP5.30M2.41%+37.7%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of OCUL

Ocular Therapeutix top fund holders
FundShares% Held
Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund9.80M4.46%
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund6.62M3.01%
iShares Trust-iShares Russell 2000 ETF5.56M2.53%
Fidelity Mt. Vernon Street Trust-Fidelity Growth Company K6 Fund2.75M1.25%
Fidelity Mt. Vernon Street Trust-Fidelity Series Growth Company Fund2.46M1.12%
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund2.26M1.03%
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund2.00M0.91%
T. Rowe Price New Horizons Fund, Inc.1.79M0.81%
iShares Trust-iShares Russell 2000 Growth ETF1.67M0.76%
Invesco Exchange-Traded Fund Trust-Invesco Pharmaceuticals ETF1.60M0.73%

Frequently asked questions

Who is the largest shareholder of Ocular Therapeutix?

FMR, LLC is the largest institutional shareholder of OCUL, owning 15.07% of shares outstanding (33.16M shares) as of its latest 13F filing.

What percentage of Ocular Therapeutix is owned by institutions?

Institutions own about 97.1% of OCUL shares and 98.5% of the public float.

How much of Ocular Therapeutix do insiders own?

Insiders, such as officers and directors, own about 1.44% of OCUL shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related